302 related articles for article (PubMed ID: 19028833)
1. Social anxiety in a multiple sclerosis clinic population.
Poder K; Ghatavi K; Fisk JD; Campbell TL; Kisely S; Sarty I; Stadnyk K; Bhan V
Mult Scler; 2009 Mar; 15(3):393-8. PubMed ID: 19028833
[TBL] [Abstract][Full Text] [Related]
2. Neurological disability, psychological distress, and health-related quality of life in MS patients within the first three years after diagnosis.
Kern S; Schrempf W; Schneider H; Schultheiss T; Reichmann H; Ziemssen T
Mult Scler; 2009 Jun; 15(6):752-8. PubMed ID: 19482864
[TBL] [Abstract][Full Text] [Related]
3. Coping and quality of life in one hundred and thirty five subjects with multiple sclerosis.
Montel SR; Bungener C
Mult Scler; 2007 Apr; 13(3):393-401. PubMed ID: 17439909
[TBL] [Abstract][Full Text] [Related]
4. Anxiety and depression in multiple sclerosis. A comparative population-based study in Nord-Trøndelag County, Norway.
Dahl OP; Stordal E; Lydersen S; Midgard R
Mult Scler; 2009 Dec; 15(12):1495-501. PubMed ID: 19965515
[TBL] [Abstract][Full Text] [Related]
5. Fatigue, depression and progression in multiple sclerosis.
Koch M; Uyttenboogaart M; van Harten A; Heerings M; De Keyser J
Mult Scler; 2008 Jul; 14(6):815-22. PubMed ID: 18535019
[TBL] [Abstract][Full Text] [Related]
6. Fatigue and social impairment in multiple sclerosis: the role of patients' cognitive and behavioral responses to their symptoms.
Skerrett TN; Moss-Morris R
J Psychosom Res; 2006 Nov; 61(5):587-93. PubMed ID: 17084135
[TBL] [Abstract][Full Text] [Related]
7. Family caregiver quality of life in multiple sclerosis among Kuwaitis: a controlled study.
Alshubaili AF; Ohaeri JU; Awadalla AW; Mabrouk AA
BMC Health Serv Res; 2008 Oct; 8():206. PubMed ID: 18840287
[TBL] [Abstract][Full Text] [Related]
8. Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study.
Patti F; Amato MP; Trojano M; Bastianello S; Tola MR; Goretti B; Caniatti L; Di Monte E; Ferrazza P; Brescia Morra V; Lo Fermo S; Picconi O; Luccichenti G;
Mult Scler; 2009 Jul; 15(7):779-88. PubMed ID: 19542262
[TBL] [Abstract][Full Text] [Related]
9. The psychosocial and cognitive impact of longstanding 'benign' multiple sclerosis.
Sayao AL; Bueno AM; Devonshire V; Tremlett H;
Mult Scler; 2011 Nov; 17(11):1375-83. PubMed ID: 21677023
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of 'poor sleep' among patients with multiple sclerosis: an independent predictor of mental and physical status.
Merlino G; Fratticci L; Lenchig C; Valente M; Cargnelutti D; Picello M; Serafini A; Dolso P; Gigli GL
Sleep Med; 2009 Jan; 10(1):26-34. PubMed ID: 18207453
[TBL] [Abstract][Full Text] [Related]
11. Associations of the Expanded Disability Status Scale with anxiety and depression in multiple sclerosis outpatients.
Tsivgoulis G; Triantafyllou N; Papageorgiou C; Evangelopoulos ME; Kararizou E; Sfagos C; Vassilopoulos D
Acta Neurol Scand; 2007 Jan; 115(1):67-72. PubMed ID: 17156268
[TBL] [Abstract][Full Text] [Related]
12. Physical activity correlates with neurological impairment and disability in multiple sclerosis.
Motl RW; Snook EM; Wynn DR; Vollmer T
J Nerv Ment Dis; 2008 Jun; 196(6):492-5. PubMed ID: 18552627
[TBL] [Abstract][Full Text] [Related]
13. Anxiety disorders and their clinical correlates in multiple sclerosis patients.
Korostil M; Feinstein A
Mult Scler; 2007 Jan; 13(1):67-72. PubMed ID: 17294613
[TBL] [Abstract][Full Text] [Related]
14. Depressive symptoms and severity of illness in multiple sclerosis: epidemiologic study of a large community sample.
Chwastiak L; Ehde DM; Gibbons LE; Sullivan M; Bowen JD; Kraft GH
Am J Psychiatry; 2002 Nov; 159(11):1862-8. PubMed ID: 12411220
[TBL] [Abstract][Full Text] [Related]
15. The burden of lower urinary tract symptoms: evaluating the effect of LUTS on health-related quality of life, anxiety and depression: EpiLUTS.
Coyne KS; Wein AJ; Tubaro A; Sexton CC; Thompson CL; Kopp ZS; Aiyer LP
BJU Int; 2009 Apr; 103 Suppl 3():4-11. PubMed ID: 19302497
[TBL] [Abstract][Full Text] [Related]
16. Psychosocial aspects of patients with focal hyperhidrosis. Marked reduction of social phobia, anxiety and depression and increased quality of life after treatment with botulinum toxin A.
Weber A; Heger S; Sinkgraven R; Heckmann M; Elsner P; Rzany B
Br J Dermatol; 2005 Feb; 152(2):342-5. PubMed ID: 15727649
[TBL] [Abstract][Full Text] [Related]
17. [Relationship between symptoms of depression and anxiety and the quality of life in multiple sclerosis].
Frühwald S; Löffler-Stastka H; Eher R; Saletu B; Baumhackl U
Wien Klin Wochenschr; 2001 Apr; 113(9):333-8. PubMed ID: 11388079
[TBL] [Abstract][Full Text] [Related]
18. Earlier disability of the patients followed in Multiple Sclerosis centers compared to outpatients.
Debouverie M; Laforest L; Van Ganse E; Guillemin F;
Mult Scler; 2009 Feb; 15(2):251-7. PubMed ID: 19181774
[TBL] [Abstract][Full Text] [Related]
19. The long-term cost of multiple sclerosis in France and potential changes with disease-modifying interventions.
Kobelt G; Texier-Richard B; Lindgren P
Mult Scler; 2009 Jun; 15(6):741-51. PubMed ID: 19383645
[TBL] [Abstract][Full Text] [Related]
20. Palliative care in patients with severe multiple sclerosis: two case reports and a survey among German MS neurologists.
Kümpfel T; Hoffmann LA; Pöllmann W; Rieckmann P; Zettl UK; Kühnbach R; Borasio GD; Voltz R
Palliat Med; 2007 Mar; 21(2):109-14. PubMed ID: 17344259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
